Oral preparation useful in measurement capacity to metabolize pyridine
US8883121B2 · kind B2 · utility
2Cited by
11References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 2006 |
| Grant date | Nov 11, 2014 |
| Priority date | — |
| Expiry date | Jul 25, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K51/1255
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An object of the present invention is to provide an oral preparation that can be used to diagnose the existence or degree of pyridine metabolic capacity disorder, pyrimidine metabolic rate, etc., with high accuracy and with little variation due to individual differences. The oral preparation is prepared using a powder material obtained by mixing and pulverizing (a) an isotope-labeled compound and/or a pyrimidine metabolite compound and (b) a sugar and/or a sugar alcohol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.